These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4610443)

  • 1. The disappearance, excretion, and metabolism of tritiated prolyl-leucyl-glycinamide in man.
    Redding TW; Kastin AJ; Gonzalez-Barcena D; Coy DH; Hirotsu Y; Ruelas J; Schally AV
    Neuroendocrinology; 1974; 16(2):119-26. PubMed ID: 4610443
    [No Abstract]   [Full Text] [Related]  

  • 2. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma.
    Nair RM; Redding TW; Kastin AJ; Schally AV
    Biochem Pharmacol; 1973 Aug; 22(15):1915-9. PubMed ID: 4578947
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution, half-life, and excretion of 14 C- and 3 H-labeled L-prolyl-L-leucyl-glycinamide in the rat.
    Redding TW; Kastin AJ; Nair RM; Schally AV
    Neuroendocrinology; 1973; 11(2):92-100. PubMed ID: 4697489
    [No Abstract]   [Full Text] [Related]  

  • 4. The half-life, metabolism and excretion of tritiated luteinizing hormone-releasing hormone (LH-RH) in man.
    Redding TW; Kastin AJ; Gonzales-Barcena D; Coy DH; Coy EJ; Schalch DS; Schally AV
    J Clin Endocrinol Metab; 1973 Oct; 37(4):626-31. PubMed ID: 4582574
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemistry of releasing hormones.
    Sandow J
    J Endocrinol; 1973 Aug; 58(2):32-3. PubMed ID: 4199267
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of melanocyte-stimulating hormone release-inhibiting factor by a manganese-stimulated bovine brain aminopeptidase.
    Simmons WH; Brecher AS
    J Biol Chem; 1973 Aug; 248(16):5780-4. PubMed ID: 4353274
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-activity studies of MSH-release-inhibiting hormone.
    Celis ME; Hase S; Walter R
    FEBS Lett; 1972 Nov; 27(2):327-30. PubMed ID: 4352026
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral effects of thyrotropin releasing hormone in animals and man: a generic hypothesis.
    Prange AJ; Wilson IC
    Psychopharmacol Bull; 1975 Jan; 11(1):22-4. PubMed ID: 804704
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
    Castensson S; Sievertsson H; Lindeke B; Sum CY
    FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothalamic releasing factors and Parkinson disease.
    Chase TN; Woods AC; Lipton MA; Morris CE
    Arch Neurol; 1974 Jul; 31(1):55-6. PubMed ID: 4209275
    [No Abstract]   [Full Text] [Related]  

  • 11. The present concept of the nature of hypothalamic hormones stimulating and inhibiting the release of pituitary hormones.
    Schally AV; Kastin AJ
    Triangle; 1969; 9(1):19-25. PubMed ID: 4980829
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemistry of the hypothalamic releasing factors--studies on structure-function relationships.
    Vale W; Grant G; Guillemin R
    Front Neuroendocrinol; 1973; 0(0):375-413. PubMed ID: 4369859
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Eur Neurol; 1974; 12(5-6):360-8. PubMed ID: 4614981
    [No Abstract]   [Full Text] [Related]  

  • 14. Intramolecular motion in peptide determined by 13C NMR: a spin-lattice relaxation time-study on MSH-release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    FEBS Lett; 1973 Nov; 37(1):27-32. PubMed ID: 4585031
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypothalamic releasing hormones. I. Structure, sources of formation, physiologic effects].
    Dedov II; Dedov VI
    Usp Sovrem Biol; 1980; 89(1):141-58. PubMed ID: 6104883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypothalamo-hypophysiotrapic hormones. 2].
    Arimura A; Matsuo H; Baba Y
    Tanpakushitsu Kakusan Koso; 1972 Aug; 17(8):620-8. PubMed ID: 4346232
    [No Abstract]   [Full Text] [Related]  

  • 17. MSH-release inhibiting factors: recent studies.
    Kastin AJ; Plotnikoff NP; Viosca S; Anderson MS; Schally AV
    Yale J Biol Med; 1973 Dec; 46(5):617-22. PubMed ID: 4591788
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone releasing effects of ACTH and -MSH in man.
    Zahnd GR; Nadeau A; von Mühlendahl KE
    Isr J Med Sci; 1972 Jun; 8(6):874-5. PubMed ID: 4340669
    [No Abstract]   [Full Text] [Related]  

  • 19. Pituitary melanocyte-stimulating hormone and its hypothalamic factors during the estrous cycle.
    Tomatis ME; Taleisnik S
    Acta Physiol Lat Am; 1968; 18(1):104-9. PubMed ID: 4873970
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypothalamic releasing hormones].
    Gilboa I
    Harefuah; 1972 Sep; 83(5):207-8. PubMed ID: 4631605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.